推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33363733,021-34612310

chinasupport@letpub.com

登录 注册 新注册优惠

Pulmonary Therapy

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 最新评论:暂无评论!


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Pulmonary Therapy期刊基本信息Hello,您是该期刊的第1418位访客

基本信息 登录收藏
期刊名字Pulmonary TherapyPulmonary Therapy


(此期刊被最新的JCR期刊ESCI收录)

LetPub评分
3.9
50人评分
我要评分

声誉
4.7

影响力
2.6

速度
7.0

期刊ISSN2364-1754
微信扫码收藏此期刊
E-ISSN2364-1746
2023-2024最新影响因子
(数据来源于搜索引擎)
2.3 点击查看影响因子趋势图
实时影响因子 -
2023-2024自引率4.30%点击查看自引率趋势图
五年影响因子0
JCI期刊引文指标 0.55
h-index 暂无h-index数据
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
5.200.7040.982
学科分区排名百分位
大类:Medicine
小类:Pulmonary and Respiratory Medicine
Q253 / 155
大类:Medicine
小类:Respiratory Care
Q21 / 1

期刊简介
Aims and Scope



Pulmonary Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad and will consider all scientifically sound research from pre-clinical, clinical (all phases), observational, real-world, and health outcomes research around the use of pulmonary therapies, devices, and surgical techniques.



Areas of focus include, but are not limited to: asthma; chronic obstructive pulmonary disease; idiopathic pulmonary fibrosis; pulmonary hypertension; cystic fibrosis; lung cancer; respiratory tract disorders; allergic rhinitis and other respiratory allergies; influenza, pneumococcal infection, respiratory syncytial virus and other respiratory infections; and inhalers and other device therapies.



The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/series, trial protocols and short communications such as commentaries and editorials. Pulmonary Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals.



Rapid Publication



The journal’s publication timelines aim for a rapid peer review of 2 weeks. If an article is accepted it will be published 3–4 weeks from acceptance. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of pulmonary therapies.

Open Access

All articles published by Pulmonary Therapy are open access.

Personal Service



The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning authors will always have an editorial contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research.



Digital Features and Plain Language Summaries



Pulmonary Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’.



For examples of digital features please visit our showcase page https://springerhealthcare.com/expertise/publishing-digital-features/



Publication Fees



Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €4500/ $5100/ £3650. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis.



Peer Review Process



Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.



At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials, and Letters which are generally reviewed by one member of the Editorial Board. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor.



Preprints



We encourage posting of preprints of primary research manuscripts on preprint servers, authors’ or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals. Authors should disclose details of preprint posting during the submission process or at any other point during consideration in one of our journals. Once the manuscript is published, it is the author’s responsibility to ensure that the preprint record is updated with a publication reference, including the DOI and a URL link to the published version of the article on the journal website.

Please follow the link for further information on preprint sharing:

https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550



Copyright



Pulmonary Therapy's content is published open access under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.



Contact



For more information about the journal, including pre-submission enquiries, please contact christopher.vautrinot@springer.com.
期刊官方网站https://www.springer.com/41030
期刊投稿网址https://www.editorialmanager.com/puth/
作者指南网址https://www.springer.com/41030/submission-guidelines
期刊语言要求Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Pulmonary Therapy的语言要求,还能让Pulmonary Therapy编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Pulmonary Therapy编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( GBP4700; USD6850; EUR5500; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:respiratory medicine、pulmonary medicine
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式
出版商Springer Nature
涉及的研究方向Medicine-Pulmonary and Respiratory Medicine
出版国家或地区United Kingdom
出版语言English
出版周期4 issues per year
出版年份0
年文章数 29点击查看年文章数趋势图
Gold OA文章占比100.00%
研究类文章占比:
文章 ÷(文章 + 综述)
65.52%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:2区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:RESPIRATORY SYSTEMESCIQ250/100
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:RESPIRATORY SYSTEMESCIQ355/101
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
(没有被最新的JCR升级版收录,仅供参考)
中国科学院SCI期刊分区
2022年12月升级版
(没有被2022年的JCR升级版收录,仅供参考)
中国科学院SCI期刊分区
2021年12月旧的升级版
(没有被旧的JCR升级版收录,仅供参考)
SCI期刊收录coverage Emerging Sources Citation Index (ESCI)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2364-1754%5BISSN%5D
平均审稿速度网友分享经验:
6 Weeks
平均录用比例网友分享经验:
版面费/APC文章处理费信息
文章处理费:需要( GBP4700; USD6850; EUR5500; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Pulmonary Therapy顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Pulmonary Therapy期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Pulmonary Therapy中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Pulmonary Therapy上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Pulmonology014.30
    European Respiratory Review014.40
    ARCHIVOS DE BRONCONEUMOLOGIA463.50
    Annals of the American Thoracic Society010.00
    ERJ Open Research06.20
    Seminars in Thoracic and Cardiovascular Surgery05.80
    Pulmonary Circulation324.20
    Multidisciplinary Respiratory Medicine184.40
    Journal of Clinical Tuberculosis and Other Mycobacterial Diseases04.00
    Current Sleep Medicine Reports02.50
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    此期刊未被最新的JCR收录
  •  

    Pulmonary Therapy Pulmonary Therapy
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    暂无!
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    此期刊未被最新的JCR收录
    同分区等级的其他期刊名称 h-index CiteScore
    此期刊未被最新的JCR收录
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共0


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室